Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Side effects during subcutaneous immunotherapy in children with allergic diseases.
Tophof MA, Hermanns A, Adelt T, Eberle P, Gronke C, Friedrichs F, Knecht R, Mönter E, Schöpfer H, Schwerk N, Steinbach J, Umpfenbach HU, Weißhaar C, Wilmsmeyer B, Bufe A. Tophof MA, et al. Among authors: bufe a. Pediatr Allergy Immunol. 2018 May;29(3):267-274. doi: 10.1111/pai.12847. Epub 2018 Jan 17. Pediatr Allergy Immunol. 2018. PMID: 29247543
High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
Wahn U, Klimek L, Ploszczuk A, Adelt T, Sandner B, Trebas-Pietras E, Eberle P, Bufe A; SLIT Study Group. Wahn U, et al. Among authors: bufe a. J Allergy Clin Immunol. 2012 Oct;130(4):886-93.e5. doi: 10.1016/j.jaci.2012.06.047. Epub 2012 Aug 29. J Allergy Clin Immunol. 2012. PMID: 22939758 Clinical Trial.
Specific immunotherapy in children.
Bufe A, Roberts G. Bufe A, et al. Clin Exp Allergy. 2011 Sep;41(9):1256-62. doi: 10.1111/j.1365-2222.2011.03740.x. Epub 2011 Apr 25. Clin Exp Allergy. 2011. PMID: 21518041 Review.
Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials.
Kaur A, Skoner D, Ibrahim J, Li Q, Lockey RF, Blaiss M, Bufe A, Andersen JS, Canonica GW, Nolte H. Kaur A, et al. Among authors: bufe a. J Allergy Clin Immunol. 2018 May;141(5):1744-1749. doi: 10.1016/j.jaci.2017.09.051. Epub 2017 Dec 5. J Allergy Clin Immunol. 2018. PMID: 29221713 Free PMC article. Clinical Trial.
Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study.
Abrahamse-Berkeveld M, Alles M, Franke-Beckmann E, Helm K, Knecht R, Köllges R, Sandner B, Knol J, Ben Amor K, Bufe A. Abrahamse-Berkeveld M, et al. Among authors: bufe a. J Nutr Sci. 2016 Oct 28;5:e42. doi: 10.1017/jns.2016.35. eCollection 2016. J Nutr Sci. 2016. PMID: 28620469 Free PMC article.
202 results